Automated Extraction of Opiates from Hydrolyzed and Non-Hydrolyzed Urine Using ISOLUTE® SLE+ Prior to GC/MS Analysis

Significance of the Topic

The automated extraction of opiates from urine samples is critical for forensic and clinical toxicology, workplace drug testing, and regulatory compliance. Efficient and reproducible preparation of hydrolyzed and non-hydrolyzed urine enables reliable quantitation of codeine, morphine, oxycodone, and related opioids by GC/MS. Reducing manual steps minimizes operator error and improves laboratory throughput, while achieving high recoveries and low variability enhances confidence in results.

Study Objectives and Overview

This application note demonstrates a fully automated workflow for extracting eight opiate analytes from urine using supported liquid extraction (SLE+) on the Biotage Extrahera system. Both acid-hydrolyzed and intact urine protocols were evaluated to meet SAMHSA and EWDTS sensitivity requirements. Key performance metrics—recoveries, precision, linearity, and limits of quantitation—were assessed to validate the method for routine drug testing.

Methodology and Protocol

Sample pretreatment differs for hydrolyzed versus non-hydrolyzed urine:

• Hydrolysis: Add internal standards, acidify with HCl, heat at 60 °C for 20 min, neutralize to pH 9.
• Non-hydrolyzed: Spike urine with internal standards and adjust alkalinity with 0.1% ammonium hydroxide.

Automated SLE extraction steps on Biotage Extrahera:

• Load 0.5–1 mL sample onto 1 mL SLE+ columns.
• Elute analytes with 4 mL dichloromethane:isopropanol (95:5, v/v).
• Evaporate extracts, reconstitute in ethyl acetate, derivatize with BSTFA+1% TMCS.

GC/MS analysis was performed under splitless injection on an Agilent 7890A/5975C system using an RXi-5ms column. SIM acquisition monitored characteristic ions for each analyte and deuterated internal standard.

Used Instrumentation

• Biotage Extrahera™ automated SLE workstation
• ISOLUTE SLE+ 1 mL sample capacity columns
• Agilent 7890A GC with QuickSwap inlet and 5975C MS detector
• TurboVap LV evaporator
• Biotage PRESSURE+ 48 positive pressure manifold (manual option)

Main Results and Discussion

Automated extraction delivered high recoveries (86–101% for hydrolyzed, 75–93% for non-hydrolyzed urine) with RSDs below 10%. Calibration curves (5–2000 ng/mL) exhibited linearity (r² > 0.99) for all analytes. Inferred limits of quantitation ranged from 5 to 60 ng/mL, satisfying workplace testing criteria. The protocol processed 24 samples in under 31–36 minutes, significantly improving throughput compared to manual methods.

Benefits and Practical Applications

• High analyte recovery and precision support accurate quantitation in forensic and clinical settings.
• Automated workflow reduces hands-on time and risk of error, enhancing laboratory efficiency.
• No emulsion formation and minimal matrix interference improve extract cleanliness for GC/MS.
• Versatile protocols accommodate both hydrolyzed and non-hydrolyzed urine samples.

Future Trends and Applications

Advances in automated SLE and on-line sample preparation will further reduce analysis time and solvent consumption. Integration with LC-MS/MS platforms can expand applicability to broader drug panels. Emerging microfluidic extraction devices may offer even faster turnaround and lower sample volumes. Continued development of deuterated internal standards and robust software will strengthen quantitative accuracy in high-throughput laboratories.

Conclusion

This application note establishes a robust, fully automated SLE-GC/MS method for opiate analysis in urine. The workflow delivers high recoveries, low variability, and sensitive quantitation that meet regulatory guidelines. Adoption of this protocol can streamline toxicology testing and improve laboratory efficiency.

Reference

No external literature references were provided in the original application note.